Rheumatoid arthritis patients on persistent moderate disease activity on biologics have adverse 5-year outcome compared to persistent low-remission status and represent a heterogeneous group

Overview of attention for article published in Arthritis Research & Therapy, September 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Dimensions has found 9 publications that cite this research output.

Article in Annals of the Rheumatic Diseases (January 2024)

Article in Rheumatology International (October 2023)

Article in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.